Data is not available at this time.
Perfect Medical Health Management Limited operates as a specialized provider of non-surgical aesthetic and wellness services across key Asian and Australian markets. The company's core revenue model is built on a high-volume, appointment-based system offering treatments including medical beauty, hair growth, pain management, and preventive care. Operating in the consumer cyclical sector, it capitalizes on growing demand for appearance-enhancement and health-maintenance services among urban populations. Its market positioning is that of an accessible premium provider, leveraging a chain of service centers to achieve economies of scale and brand recognition. The firm distinguishes itself through a integrated service portfolio that combines aesthetic treatments with broader health management, catering to a clientele seeking holistic well-being solutions. This strategic focus on non-invasive procedures allows for repeat customer visits and stable cash flow generation, underpinning its established presence in a competitive and rapidly evolving personal care industry.
The company generated HKD 1.13 billion in revenue with a net income of HKD 206.9 million, reflecting an 18.3% net margin. Strong operating cash flow of HKD 332.9 million significantly exceeded net income, indicating high-quality earnings and efficient cash conversion from its service-based operations, with modest capital expenditure requirements relative to cash generation.
Diluted EPS stood at HKD 0.16, demonstrating the firm's ability to translate top-line performance into shareholder returns. The substantial operating cash flow highlights robust core earnings power, efficiently funding operations and investments without excessive capital intensity, as evidenced by manageable capex levels.
The balance sheet shows a solid liquidity position with HKD 249.1 million in cash against total debt of HKD 216.6 million, indicating a conservative leverage profile. This financial structure provides flexibility for ongoing operations and potential strategic initiatives while maintaining a healthy cushion for uncertainties.
The company maintains a shareholder-friendly approach, distributing a dividend of HKD 0.166 per share. This payout, exceeding the diluted EPS, suggests a commitment to returning capital to investors, potentially supported by strong cash flow generation rather than solely current period earnings.
With a market capitalization of approximately HKD 1.95 billion, the market values the company at roughly 1.7 times revenue and 9.4 times net income. A beta of 0.997 indicates stock performance closely aligned with broader market movements, reflecting typical cyclical consumer sector volatility expectations.
The company's strategic advantages include its established brand, diversified service portfolio, and geographic footprint across growing Asian markets. Its asset-light service model and strong cash flow generation provide a solid foundation for sustained operations and potential regional expansion in the competitive aesthetic and wellness services industry.
Company Annual ReportHong Kong Stock Exchange Filings
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |